Skip to search.
 TSX Down0.74% TSX Ventures 0.00%

Cyclacel Pharmaceuticals, Inc. (CYCC)

-NasdaqGM

3.18 Up 0.19(6.35%) 4:00PM EDT|After Hours : 3.21 Up 0.03 (0.94%) 4:17PM EDT - Nasdaq Real Time Price

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period Ending2012-12-302011-12-302010-12-30
Total Revenue 69   -   112  
Cost of Revenue -   -   -  
Gross Profit 69   -   112  
Operating Expenses
Research Development6,592  9,206  6,414  
Selling General and Administrative8,580  6,542  8,833  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (15,103) (15,748) (15,135)
Income from Continuing Operations
Total Other Income/Expenses Net(4)580  (369)
Earnings Before Interest And Taxes(15,107)(15,168)(15,504)
Interest Expense -   -  43  
Income Before Tax(15,107)(15,168)(15,547)
Income Tax Expense(1,351)(565)(657)
Minority Interest -   -   -  
Net Income From Continuing Ops(13,756)(14,603)(14,890)
Non-recurring Events
Discontinued Operations570  (640)(1,131)
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (13,186) (15,243) (16,021)
Preferred Stock And Other Adjustments(728)(728)(3,682)
Net Income Applicable To Common Shares (13,914) (15,971) (19,703)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.